These sources consist of legitimate science or are evidence-based through credible scientific sourcing. Legitimate science follows the scientific method, is unbiased, and does not use emotional words. These sources also respect the consensus of experts in the given scientific field and strive to publish peer-reviewed science. Some sources in this category may have a slight political bias but adhere to scientific principles. See all Pro-Science sources.
- Overall, we rate the Journal of Experimental & Clinical Cancer Research as a Pro-Science open-source journal. We also rate them High for factual reporting due to a clean fact check record.
Bias Rating: PRO-SCIENCE
Factual Reporting: HIGH
Country: United Kingdom
MBFC’s Country Freedom Rank: MOSTLY FREE
Media Type: Organization/Foundation
Traffic/Popularity: Minimal Traffic
MBFC Credibility Rating: HIGH CREDIBILITY
The Journal of Experimental & Clinical Cancer Research is a peer-reviewed open-access journal published by BioMed Central (BMC) covering Cancer Research According to its about page, “Journal of Experimental & Clinical Cancer Research is an online peer-reviewed journal that publishes original research papers, reviews and commentaries in cancer research, from bench to bedside..”
Founded in 2000, BioMed Central, or BMC, is a United Kingdom-based, for-profit scientific open-access publisher. They publish more than 300 journals that are entirely online. According to their about page, “Our leading research journals include selective titles such as BMC Biology, BMC Medicine, Genome Biology and Journal of Experimental & Clinical Cancer Research, academic journals such as Journal of Hematology & Oncology, Malaria Journal, and Microbiome, and the BMC series, 65 inclusive journals focused on the needs of individual research communities. We also partner with leading institutions and societies to publish journals on their behalf.”
Funded by / Ownership
BioMed Central is owned by Springer Nature, an academic publishing company created by the May 2015 merger of Springer Science+Business Media and Holtzbrinck Publishing Group’s Nature Publishing Group, Palgrave Macmillan, and Macmillan Education. The company reported revenues of over 1 billion USD.
Analysis / Bias
Journal of Experimental & Clinical Cancer Research is an open-access journal that publishes information and research related to cancer research. The journal primarily publishes research like this Paracrine activin B-NF-κB signaling shapes an inflammatory tumor microenvironment in gastric cancer via fibroblast reprogramming.
BioMed Central (BMC) is an open-access publisher of scientific journals. There are two types of Open Access Journals, legitimate and predatory, both of which charge the author for publication. Predatory journals often lack peer review and are generally considered not credible. BioMed Central is considered a legitimate, open-access publisher that is frequently indexed in PubMed. However, BMC journals have been criticized for retracting numerous studies due to fake peer reviews or poor methodology.
Although BMC has retracted some studies in other publications that were found to be of poor methodology and not thoroughly peer-reviewed, the Journal of Experimental & Clinical Cancer Research publishes credible scientific studies that are factual and appropriately peer-reviewed.
Failed Fact Checks
- None by the Journal of Experimental & Clinical Cancer Research; however, BioMed Central has.
Overall, we rate the Journal of Experimental & Clinical Cancer Research as a Pro-Science open-source journal. We also rate them High for factual reporting due to a clean fact check record. (D. Van Zandt 10/19/2023)
Last Updated on October 19, 2023 by Media Bias Fact Check
Do you appreciate our work? Please consider one of the following ways to sustain us.